Innovar Interactions
There are 751 drugs known to interact with Innovar (droperidol / fentanyl), along with 21 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 436 are major, 312 are moderate, and 3 are minor.
- View all 751 medications that may interact with Innovar
- View Innovar alcohol/food interactions (1)
- View Innovar disease interactions (21)
Most frequently checked interactions
View interaction reports for Innovar (droperidol / fentanyl) and the medicines listed below.
- Ambien (zolpidem)
- atorvastatin
- atropine
- baclofen
- clonazepam
- epinephrine
- Estrogel (estradiol)
- Gralise (gabapentin)
- ketamine
- Levothroid (levothyroxine)
- metformin
- Metoprolol Tartrate (metoprolol)
- midazolam
- morphine
- MS Contin (morphine)
- Nitrostat (nitroglycerin)
- nitrous oxide
- Norco (acetaminophen / hydrocodone)
- Nucynta (tapentadol)
- Phenergan (promethazine)
- Prilosec OTC (omeprazole)
- progesterone
- quetiapine
- Savella (milnacipran)
- sertraline
- terazosin
- Testopel Pellets (testosterone)
- trazodone
- Xanax (alprazolam)
Innovar alcohol/food interactions
There is 1 alcohol/food interaction with Innovar (droperidol / fentanyl).
Innovar disease interactions
There are 21 disease interactions with Innovar (droperidol / fentanyl) which include:
- cardiovascular
- QT prolongation
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- hepatic/renal dysfunction
- pheochromocytoma
- fever
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.